Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × aldesleukin × 1 year × Clear all

Sponsor

Conditions

Melanoma 14 Neoplasm Metastasis 9 Pancreatic Neoplasms 8 Ovarian Neoplasms 8 Stomach Neoplasms 7 Leukemia, Myeloid, Acute 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Skin Neoplasms 5 Colorectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Neuroblastoma 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Leukemia 3 Hematologic Neoplasms 3 Gastrointestinal Neoplasms 3 Colonic Neoplasms 3 Vulvar Neoplasms 2 Urogenital Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Lung Neoplasms 2 Leukemia, Myeloid 2

Interventions

Specimen Handling 7 Biopsy 6 Cyclophosphamide 5 ruxolitinib 4 Mycophenolic Acid 4 Busulfan 4 fludarabine phosphate 3 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Melphalan 3 Injections 3 Decitabine 3 Cyclosporine 3 Azacitidine 3 venetoclax 2 decitabine and cedazuridine drug combination 2 Sirolimus 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 veliparib 1 tocilizumab 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 gilteritinib 1 fedratinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡